Table 1.
Characteristics (n = 32) | Results |
---|---|
Age(years), mean (SD) | 74 (7) |
Male, n (%) | 32 (100) |
Current smoker, n (%) | 1 (3) |
Pack-year, mean (SD) | 60.6 (30.8) |
BMI (Kg/m2), mean (SD) | 24.1 (4) |
Bronchiectasis, CT scan, n (%) | 25 (78) |
Lung function, mean (SD) | |
FEV1, liters | 0.98 (0.4) |
FEV1, % predicted | 34.4 (13.7) |
FVC, liters | 2.5 (0.6) |
FVC, % predicted | 61.4 (15.6) |
FEV1/FVC % | 39.4 (10.7) |
pO2 (mmHg) | 62.4 (10.4) |
pCO2 (mmHg) | 43.8 (6.4) |
BODE index | 4.6 (1.6) |
COPD treatment, n (%) | |
Inhaled triple therapy (LAMA+LABA+ICs) | 25 (78) |
Roflumilast | 1 (3) |
Theophylline | 2 (6) |
Chronic oxygen therapy | 13 (41) |
Abbreviations: COPD, chronic obstructive pulmonary disease; SD, standard deviation; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; BMI, body mass index; BODE index, body mass index, airflow obstruction, Dyspnea and exercise capacity index; LAMA, Long-acting anti-muscarinic; LABA, long-acting β-Agonist; ICs, inhaled corticosteroids; CT, computed tomography.